Sugar and Gold Forms Basis for Fast Specific Flu Test
News Dec 09, 2013
If the flu virus is detected, the rich red of the gold solution will change colour, creating a quick and simple technique that has the potential for use worldwide with minimal training.
The team is a collaboration led by Professor Rob Field of the John Innes Centre and Professor David Russell of University of East Anglia. Prof Russell has already founded a spinout company – Intelligent Fingerprinting that detects drugs and drug metabolites in fingerprints – to exploit his previous work on optically based molecular recognition systems.
Professor Field explains that 90% of infections use carbohydrate recognition to bind with their targets in the human body and this process can be used as a basis for sensor development. He says the same basic principles can be applied wherever rapid detection is required from detecting superbugs in hospitals to biohazards such as ricin.
“We have already developed a carbohydrate-based sensor to detect cholera in contaminated water supplies. The sensor is a suspension of sugars tagged with inexpensive gold nanoparticles. If cholera is present it will attach to the sugar pulling the particles closer together. This creates a change in the photophysics of the suspension, resulting in a colour change that is visible to the naked eye.
“We are now applying these principles to influenza. We have found that different types of flu virus have different sugar binding capabilities, so it is therefore possible to use a colour change not only to identify the presence and absence of the virus but also to distinguish between them.”
On the surface of the human cell are sugar chains containing a molecule called sialic acid. Researchers have found that human flu and avian flu both have receptors for sialic acid but with a preference for different sugar chains. This can be used to differentiate between the flu virus strains.
Professor Russell explained that the new assay based on gold nanoparticles is much faster than current methods of detection.
“Preventing a new influenza pandemic requires both vaccination and antiviral drugs administered within 48 hours of the infection. Current methods of detection require isolation and culture of the virus and may take several hours or even days to get the results; which can be too long for the patient. It is clear that a rapid, diagnostic test that is able to discriminate between the different strains of virus is essential.”
Results recently published in Organic & Biomolecular Chemistry* showed that functionalized gold nanoparticles were able to detect the human influenza virus X31 (H3N2) within 30 minutes and it was able to distinguish between human and avian influenza, which is exceptionally important. This provides proof of concept for this innovative bioassay, which has potential for the specific recognition and detection of influenza virus strains in clinical samples.
Professor Field says the low-tech approach makes it a quick and easy dipstick test that can be used in the field with little training.
After successfully patenting the technique the researchers are now looking for a diagnostics company to partner with to bring it to market.
* Paper reference: Org. Biomol. Chem., 2013,11, 7101-7107 DOI: 10.1039/C3OB41703D
Study Reveals How MRSA Infection Compromises Lymphatic FunctionNews
Infections of the skin or other soft tissues with the hard-to-treat MRSA bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. Investigators describe how MRSA infection impairs the ability of lymphatic vessels to pump lymphatic fluid to lymph nodes in mouse models, which may contribute to the frequent recurrences of MRSA infection experienced by patients.
Possible Biomarker to Identify Who Would Benefit from ImmunotherapyNews
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments. In a new study, researchers examined tissue samples from melanoma and ovarian cancer patients treated with immunotherapies and found a link between the percentage of antigen-presenting cells expressing PD-L1 and an objective clinical response to treatment.READ MORE
Fight Against Cancer: Drug Combination Helps Kickstart the Immune SystemNews
Scientists from King's College London have found a way to boost the immune system to help it fight back against cancer.
The breakthrough involves the first ever use of a combination of chemotherapy and a drug being trialled as a treatment for neonatal jaundice, that together help kick start the body's natural defences.